Cargando…

Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c/FASN axis

Detalles Bibliográficos
Autores principales:	Deng, Jun, Peng, Mei, Zhou, Sichun, Xiao, Di, Hu, Xin, Xu, Simeng, Wu, Jingtao, Yang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921554/ https://www.ncbi.nlm.nih.gov/pubmed/33649289 http://dx.doi.org/10.1038/s41392-021-00493-8

Ejemplares similares

SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
por: Jin, Yuxiao, et al.
Publicado: (2021)

Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy
por: Xiao, Di, et al.
Publicado: (2022)

Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL
por: Chi, Cheng, et al.
Publicado: (2022)

The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019)

FASN-dependent de novo lipogenesis is required for brain development
por: Gonzalez-Bohorquez, Daniel, et al.
Publicado: (2022)

Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis
por: Han, Zelong, et al.
Publicado: (2022)

Cdk8 attenuates lipogenesis by inhibiting SREBP-dependent transcription in Drosophila
por: Li, Xiao, et al.
Publicado: (2022)

An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth
por: Liu, Liu, et al.
Publicado: (2021)

RA-XII Suppresses the Development and Growth of Liver Cancer by Inhibition of Lipogenesis via SCAP-dependent SREBP Supression
por: Guo, Di, et al.
Publicado: (2019)

FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
por: Wei, Wenxia, et al.
Publicado: (2023)

Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
por: Xiong, Wenfang, et al.
Publicado: (2021)

Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
por: Zhao, Qiushi, et al.
Publicado: (2022)

Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumor growth
por: Cheng, Chunming, et al.
Publicado: (2022)

Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells
por: Li, Ling, et al.
Publicado: (2019)

Nifedipine Modulates Renal Lipogenesis via the AMPK-SREBP Transcriptional Pathway
por: Lin, Yen-Chung, et al.
Publicado: (2019)

Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells
por: Tiong, Tung-Yu, et al.
Publicado: (2022)

Visualization and quantification of de novo lipogenesis using a FASN-2A-GLuc mouse model
por: Li, Wenjiao, et al.
Publicado: (2022)

Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019)

NRF3 upregulates gene expression in SREBP2-dependent mevalonate pathway with cholesterol uptake and lipogenesis inhibition
por: Waku, Tsuyoshi, et al.
Publicado: (2021)

Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
por: Yao, Jian, et al.
Publicado: (2023)

Oncogenic signaling upstream of mTORC1 drives lipogenesis and proliferation through SREBP
por: Ricoult, Stéphane, et al.
Publicado: (2014)

SREBP-2, a new target of metformin?
por: Zhang, Fengxia, et al.
Publicado: (2018)

Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
por: Talebi, Ali, et al.
Publicado: (2018)

Inhibition of PKM2 Enhances Sensitivity of Olaparib to Ovarian Cancer Cells and Induces DNA Damage
por: Zhou, Sichun, et al.
Publicado: (2022)

Vitamin A prevents lipopolysaccharide‐induced injury on tight junctions in mice
por: He, Caimei, et al.
Publicado: (2020)

Novel application of metformin combined with targeted drugs on anticancer treatment
por: Deng, Jun, et al.
Publicado: (2018)

Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells
por: Loubière, Camille, et al.
Publicado: (2015)

Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice
por: Linden, Albert G., et al.
Publicado: (2018)

MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer
por: Tibbo, Amy J., et al.
Publicado: (2023)

Dihydrotestosterone induces SREBP-1 expression and lipogenesis through the phosphoinositide 3-kinase/Akt pathway in HaCaT cells
por: Zhou, Bing-rong, et al.
Publicado: (2012)

Cytoplasmic Clusterin Suppresses Lung Cancer Metastasis by Inhibiting the ROCK1-ERK Axis
por: Huang, Shaobo, et al.
Publicado: (2022)

The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model
por: Papaevangelou, Efthymia, et al.
Publicado: (2018)

Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism
por: Shen, Juan, et al.
Publicado: (2022)

CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
por: Zeng, Han, et al.
Publicado: (2021)

The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis
por: Wang, Yongjia, et al.
Publicado: (2022)

A novel small compound TOIDC suppresses lipogenesis via SREBP1-dependent signaling to curb MAFLD
por: Shao, Yaodi, et al.
Publicado: (2022)

Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer
por: Xu, Chuncao, et al.
Publicado: (2021)

Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
por: Sun, Tianhao, et al.
Publicado: (2019)

SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma
por: Sethi, Gautam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5dh0utqqdtt7cn559sdskb6it4